DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
73.52
-1.80 (-2.39%)
At close: Mar 25, 2025, 4:00 PM
73.56
+0.04 (0.05%)
After-hours: Mar 25, 2025, 6:26 PM EST
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$391,553
Profits / Employee
$55,942
Market Cap
28.73B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DXCM News
- 9 hours ago - Dexcom Appoints Jon Coleman as Chief Commercial Officer - Business Wire
- 13 hours ago - Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom - Business Wire
- 6 days ago - Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care - Business Wire
- 11 days ago - History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now - Seeking Alpha
- 15 days ago - Dexcom Appoints Renée Galá to Board of Directors - Business Wire
- 18 days ago - Dexcom receives FDA warning letter for two U.S. manufacturing facilities - Reuters
- 18 days ago - DexCom Gets FDA Warning Letter After Inspections of Facilities - WSJ
- 21 days ago - DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript) - Seeking Alpha